TelyRx Holdings Inc. has seen a notable shift in its stock performance recently, with a weekly gain amidst significant financial announcements.
This week, TelyRx Holdings Inc. (TELY.TO) experienced a 4.65% increase in stock price, closing at C$2.25. Despite a slight decline of 1.75% on the last trading day, the company has made headlines with its recent financial results and strategic developments. Let’s take a closer look at the latest updates and the technical picture surrounding TelyRx.
Investor takeaway: Investors should note the recent revenue growth reported by TelyRx, which may indicate a positive trajectory for the company despite its current stock price challenges. The significant difference between the current trading price and analyst targets suggests potential for future appreciation, although caution is warranted given the company's recent volatility.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$59.83M
52W high
$4.25
52W low
$2.00
1W change
+4.65%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 166.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+166.7% Upside
Current Price
C$2.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
67.4%
Annualized
90-Day Vol
90.0%
Annualized
Trend (90d)
-21.8%
Annualized drift
90d Mean
C$2.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.19 | C$1.74 – C$2.77 |
| 60 trading days | C$2.14 | C$1.54 – C$2.97 |
| 90 trading days | C$2.08 | C$1.39 – C$3.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
C$2.25 Closing Price Reflects Market Sentiment
With a market capitalization of approximately C$59.83 million and a 52-week range of C$2.00 to C$4.25, TelyRx's stock price remains near the lower end of its historical performance.
Bull case
TelyRx has announced impressive revenue growth for both the year-end 2025 and the first quarter of 2026, showcasing strong operational performance that could lead to future gains. The completion of its qualifying transaction and entry into the OTCQX market may also enhance visibility and accessibility to investors.
Bear case
Despite the positive revenue growth, TelyRx's stock has underperformed year-to-date, down 35.71%. The company's negative profit margin and low return on equity raise concerns about its financial health and sustainability. Additionally, the current trading volume is significantly lower than its average, indicating reduced investor interest.
Recent Price Action
TelyRx Holdings Inc. closed at C$2.25, reflecting a 1.75% decline on the last trading day. However, the stock has increased by 4.65% over the past week, indicating some positive movement amidst broader market fluctuations.
Advertisement
Catalysts for Recent Activity
TelyRx has made headlines with the announcement of its year-end 2025 financial results, reporting a significant revenue increase to $42.9 million, up from $9.5 million in 2024. Additionally, the first quarter of 2026 saw revenues rise to $19.4 million from $6.9 million in Q1 2025. These results highlight the company's growth trajectory and operational success.
Technical Picture
From a technical standpoint, TelyRx's stock is trading below both its 50-day moving average of C$2.54 and its 200-day moving average of C$2.69, indicating a bearish trend. The stock has a beta of 0.0, suggesting lower volatility compared to the market. The current volume of 1,600 shares is significantly below the 20-day average volume of 50,179 shares, reflecting decreased trading activity.
Insider Activity
On September 14, 2026, TN Group Volunteers Ltd., owned by Benjamin Atkins, disclosed the purchase of 912,933 subordinate voting shares at C$2.59 per share. This insider buying could signal confidence in the company’s future prospects.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
